irbesartan
Showing 1 - 25 of 59
Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine FDC, Irbesartan, Amlodipine)
Active, not recruiting
- Healthy Volunteers
- Irbesartan/Amlodipine FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 8, 2023
Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine High FDC, Irbesartan, Amlodipine High)
Active, not recruiting
- Healthy Volunteers
- Irbesartan/Amlodipine High FDC
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Jan 8, 2023
Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine low, Irbesartan/Amlodipine high, Irbesartan)
Recruiting
- Essential Hypertension
- Irbesartan/Amlodipine low
- +2 more
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 24, 2022
Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine, Irbesartan)
Recruiting
- Essential Hypertension
- Irbesartan/Amlodipine
- Irbesartan
-
Seoul, Korea, Republic ofHanyang University Seoul Hospital
Jul 24, 2022
Bariatric Surgery and Pharmacokinetics of Irbesartan
Recruiting
- Obesity, Morbid
- Irbesartan
-
Trondheim, NorwaySt. Olavs University Hospital
Apr 1, 2022
CKD5 Stage Dialysis, Heart Failure Trial in Shanghai (Sacubitril/Valsartan, Irbesartan)
Recruiting
- CKD5 Stage Dialysis
- Heart Failure
- Sacubitril/Valsartan
- Irbesartan
-
Shanghai, Shanghai, ChinaDepartment of Nephrology, Ruijin Hospital, School of Medicine, S
Feb 20, 2022
Diabetic Nephropathy Trial in Naples (SoC therapy, irbesartan, ramipril)
Completed
- Diabetic Nephropathy
- SoC therapy
- +13 more
-
Naples, ItalyDepartment of Advanced Medical and Surgical Sciences, Università
Jul 31, 2020
Type 2 Diabetic Nephropathy Trial in Changsha, Chenzhou, Yiyang (Alfacalcidol, Irbesartan)
Completed
- Type 2 Diabetic Nephropathy
- Alfacalcidol
- Irbesartan
-
Changsha, Hunan, China
- +2 more
Oct 9, 2019
Ehlers-Danlos Syndrome, Vascular Type Trial in France (Irbesartan, Placebo)
Completed
- Ehlers-Danlos Syndrome, Vascular Type
- Irbesartan
- Placebo
-
Bordeaux, France
- +14 more
Nov 2, 2020
Focal Segmental Glomerulosclerosis Trial in Worldwide (sparsentan, Irbesartan)
Active, not recruiting
- Focal Segmental Glomerulosclerosis
- sparsentan
- Irbesartan
-
Mesa, Arizona
- +224 more
Oct 27, 2022
IgA Nephropathy Trial in Guangzhou (irbesartan, methylprednisolone (MP) or prednisone (pred), mycophenolate mofetil (MMF))
Completed
- IgA Nephropathy
- irbesartan
- +2 more
-
Guangzhou, Guangdong, ChinaThe 1st Affiliated Hospital, Sun Yet-sen University
Dec 1, 2019
Hypertension, Obesity, Stress, Psychological Trial in Augusta (Irbesartan, Placebo)
Unknown status
- Hypertension
- +3 more
- Irbesartan
- Placebo
-
Augusta, GeorgiaAugusta University
Jun 19, 2019
Renal Insufficiency, Chronic, Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Placebo, Lisinopril)
Recruiting
- Renal Insufficiency, Chronic
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- +4 more
-
Tucson, Arizona
- +281 more
Jan 10, 2023
Obesity and Glomerulopathy Trial in Nanjing (High dosage Sevelamer Carbonate + Irbesartan, Low dosage Sevelamer Carbonate +
Terminated
- Obesity and Glomerulopathy
- High dosage Sevelamer Carbonate + Irbesartan
- +2 more
-
Nanjing, Jiangsu, ChinaResearch Institute of Nephrology, Jinling Hospital, Nanjing Univ
Sep 29, 2018
Preeclampsia, Pregnancy Induced Hypertension Trial in Boston (Irbesartan)
Suspended
- Preeclampsia
- Pregnancy Induced Hypertension
- Irbesartan
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 15, 2019
Hypertension Trial in San Antonio (Irbesartan, Avapro)
Completed
- Hypertension
- Irbesartan
- Avapro
-
San Antonio, TexasWorldwide Clinical Trials Drug Development Solutions (formerly C
Jan 19, 2018
Hypertension Trial in San Antonio (Irbesartan, Avapro)
Completed
- Hypertension
- Irbesartan
- Avapro
-
San Antonio, TexasWorldwide Clinical Trials Drug Development Solutions (formerly C
Jan 19, 2018
Hypertension Trial in Stockholm (Irbesartan, Atenolol)
Completed
- Hypertension
- Irbesartan
- Atenolol
-
Stockholm, SwedenKarolinska Institutet, Daprtment of Clinical Sciences, Danderyd
May 3, 2015
CHF Trial in Worldwide (Irbesartan, Placebo)
Completed
- Congestive Heart Failure
- Irbesartan
- Placebo
-
Birmingham, Alabama
- +230 more
Mar 18, 2015
Obesity, Hypertension Trial in Thessaloniki (Irbesartan, Amlodipine)
Withdrawn
- Obesity
- Hypertension
- Irbesartan
- Amlodipine
-
Thessaloniki, GreeceHypertension-24h ABPM Center Papageorgiou Hospital
Feb 10, 2014
Hepatitis C, Chronic Trial in Angers (Irbesartan, )
Completed
- Hepatitis C, Chronic
- Irbesartan
- placebo
-
Angers, FranceCHU Angers, Service d'hépato-gastroentérologie
Feb 6, 2014